We serve 2-phenylethylamine CAS:64-04-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-phenylethylamine
CAS.NO: 64-04-0
Synonyms:
1-amino-2-phenylethane
phenylethylamine
2-phenylethanamine
2-Phenethylamine
1-phenyl-2-aminoethane
Phenethylamine
2-Phenylethylamine
Benzeneethanamine
Molecular Formula: C8H11N
Molecular Weight: 121.18000
Physical and Chemical Properties:
Density: 0.962 g / mL at 20 ° C (lit.)
Boiling point: 197-200 ° C (lit.)
Melting point: -60 ° C
Flash point: 195 ° F
Refractive index: n20 / D 1.533 (lit.)
Specification:
Appearance: Colorless Liquid
Purity:≥98%
moisture:0.5%max
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Storage condition:2-8°C.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Solifenacin succinate CAS:242478-38-2
Intermediates of Solifenacin CAS:242478-37-1
Contact us for information like 2-phenylethylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzeneethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Phenylethylamine Use and application,2-Phenylethylamine technical grade,usp/ep/jp grade.
Related News: But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said.methyl 3-bromobutanoate manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.Methyl (2E)-3-[3-(trifluoromethyl)phenyl]acrylate supplier First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.3-Aminophenylacetylene vendor There’s a few factors that play into this.In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.
